Gilles Meshaka

Gilles Meshaka has extensive experience in leadership and investment within the biotechnology and healthcare sectors. Currently serving as Directeur Général at BIOALLIANCE since 2004, Meshaka also holds the position of Principal Investigator (PI) at Y TREE, Outcomes4Me, Cityzia, and GenePred Biotechnologies, while contributing as a PI and advisory board member at the World Gaming Federation. Notably, from 2004 to 2015, Meshaka played a pivotal role as a pioneer investor and board member at LABCO SA, later SYNLAB France, co-founding LABCO DIAGNOSTICS and remaining involved until its acquisition by Cinven private equity.